Verhoef, T. I., Redekop, W. K., Hasrat, F., de Boer, A., & Maitland-van der Zee, A. H. (2014). Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings. Am J Cardiovasc Drugs.
Styl ChicagoVerhoef, Talitha I., William K. Redekop, Fazila Hasrat, Anthonius de Boer, a Anke Hilse Maitland-van der Zee. "Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation in Two Different European Healthcare Settings." Am J Cardiovasc Drugs 2014.
Citace podle MLAVerhoef, Talitha I., et al. "Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation in Two Different European Healthcare Settings." Am J Cardiovasc Drugs 2014.